CDC Website CDC Website

To Join the NPIN community or

Home » A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay

Centers for Disease Control and Prevention, National Center for HIV Viral Hepatitis STD and TB Prevention
Thumbnail image of A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay
This information sheet discusses the Xpert MTB/RIF Assay for diagnosing TB. It explains that the new test is a nucleic acid amplification test that diagnoses TB in less than 2 hours and can also determine resistance to rifampin, one of the drugs used to treat TB. The information sheet describes how the Xpert MTB/RIF assay works, its advantages, how the results should be interpreted, what it means if RIF resistance is detected, not detected, or is indeterminate. Addresses for additional information are provided.
Disease
TB
Topics/Subjects
Testing and Counseling
Subjects
Drug Resistance
Year of Publication
2014
Format
Information Sheet
Physical Description
2 p. col.

Last Updated Date: 

8/19/15

Publication ID: 

35762